Latest News about DMT
Recent news which mentions DMT
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
From Benzinga
Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief
November 07, 2024
From Benzinga
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials
September 05, 2024
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
July 25, 2024
From Benzinga
Divine Supply: How A California Church Became A Psychedelics And Weed Sanctuary Challenging Federal Prohibition
May 06, 2024
Tickers
DMT
From Benzinga
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
February 21, 2024
From Benzinga
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
January 02, 2024
From Benzinga
More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health
December 13, 2023
From Benzinga
Psychedelics In Mexico: Are They Legal? Well, Yes And No
December 10, 2023
Tickers
DMT
From Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
October 20, 2023
From Benzinga
The Fear Of Death Dissolved: How Psychedelic Trips And Near-Death Moments Change Our Outlook On Life's End
August 17, 2023
Tickers
DMT
From Benzinga
DMT VS. Psilocybin: Are We All Experiencing The Same Trip?
February 10, 2023
Tickers
DMT
From Benzinga
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
February 01, 2023
From Benzinga
Top 3 Psychedelic Storylines To Watch In 2023
January 29, 2023
From Benzinga
EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
January 26, 2023
From Benzinga
From Benzinga
Ayahuasca's Benefits Outweigh Risks, A New Australian Study Finds
November 28, 2022
Tickers
DMT
From Benzinga
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
October 31, 2022
From Benzinga
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
September 12, 2022
From Benzinga
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
August 29, 2022
From Benzinga
From Benzinga
Top 5 Most Influential Psychedelic Studies
March 29, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.